While markets await a Saudi update, investors are likely asking how the kingdom left itself so vulnerable, and what it means for the future.Energyread more
Of the recessions the U.S. has seen dating back to the early 1980s, none has come without an oil spike of at least 90%.Economyread more
An oil processing facility at Abqaiq and the nearby Khurais oil field was attacked on Saturday.Marketsread more
Energy stocks, one of the worst-performing sector this year, spiked on Monday after an attack on Saudi Arabia's heart of oil production Saturday sent oil prices soaring.Marketsread more
Shares of defense companies rose on Monday after the United States military was put on alert by President Donald Trump.Marketsread more
The Saudi-led military coalition battling Yemen's Houthi movement said on Monday that the attack on Saudi oil plants was carried out by Iranian weapons and did not originate...Oilread more
Stocks fell on Monday amid fears that a surge in oil prices following an attack in Saudi Arabia could slow down global economic growth.Marketsread more
New research by the Digital Citizens Alliance shows how easy it is to buy illegal steroids and other appearance- and performance-enhancing drugs.Cybersecurityread more
GM shares were down nearly 3% Monday as analysts estimated the strike could cost GM tens of millions of dollars per day. The two sides resumed talks at 10 a.m. Monday...Autosread more
Amazon changed the algorithms that power its product-search system to favor the company's own products, The Wall Street Journal reported.Technologyread more
Between 180 and 200 underperforming GameStop stores are set to shutter before the end of the fiscal year, and more could be on the way.Entertainmentread more
Cedric Meury, a software engineer living from Switzerland, has long been curious about his health. So he ordered a DNA test in May from a bio-tech start-up with operations in the U.S. and Europe run by a former Amazon product manager.
But when Dante Labs' kit arrived in the mail, a few things seemed off. The return instructions and manual were missing. And the tube where he would have deposited his spit sample was filled to the brim with bubbly liquid and sealed up in a biohazard bag.
At that point, Meury realized that he had been sent a used kit.
The tube contained another person's saliva.
Meury fired off a letter with his concerns to Dante Labs and received a response within a few days acknowledging the mistake.
In an email to CNBC, which the company subsequently posted to its blog, Riposati said the start-up used a third party to ship the saliva collection kits and return them using a UPS or FedEx prepaid shipping label.
"For five orders, this partner printed the wrong return shipping labels and received the five kits back in its facility. Then, the partner managed these used kits as new units and fulfilled five new orders with them," he said.
Riposati said the used kits did not disclose any personally identifiable information, so it didn't violate customers' privacy.
The company didn't name its third party provider, stating that it took "full responsibility" for the mistake. It also stressed that its overall error rate is 0.5 percent, which it admitted is still "too high."
The market for DNA testing has exploded in the past decade, with consumer demand increasing and costs continuing to plummet. Researchers expect that the global consumer DNA testing market will reach $928 million by 2023.
Many of these companies sell their kits directly to consumers on their own websites, as well as on Amazon, which is making a big push to sell health tests on its marketplace.
But in recent months, several of these companies have come under fire. An investigation from NBC Chicago in April found that at least one provider couldn't tell the difference between the DNA of a dog and a human. Another from January found widely varying results for different ancestry tests. And in 2017, the feds stepped in when a company tried to give away DNA tests at a football game without the proper licensing.
The site 23andMe in its first years of operations in 2010 admitted to incorrectly processing samples, resulting in up to 96 customers receiving DNA results that were not their own.
"It's a growing industry with growing pains," said Robert Green, a medical geneticist at Brigham and Women's Hospital and professor of medicine at Harvard Medical School.
Green said errors occur even in the best labs, and genetic testing companies are no exception.
But scientists and policymakers are increasingly calling for more regulation to ensure that consumers are making informed decisions and the companies are facing more rigorous standards.
University of Michigan Medical School bioethicist Kayte Spector-Bagdady said sending used samples to customers raises questions about the validity of results and whether the company is making similar mistakes.
But she's more concerned ultimately about whether direct-to-consumer DNA testing companies are taking adequate steps to provide accurate health results. "Cases like these might be gross, but it's not all that different to stepping on a chewed up piece of gum," she said.